Ronald M. Razmi - Apr 27, 2022 Form 4 Insider Report for Deep Medicine Acquisition Corp. (DMAQ)

Role
Director
Signature
/s/ Ronald M. Razmi
Stock symbol
DMAQ
Transactions as of
Apr 27, 2022
Transactions value $
$0
Form type
4
Date filed
4/27/2022, 04:32 PM
Previous filing
Oct 26, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DMAQ Class B Common Stock Other $0 +50K $0.00 50K Apr 27, 2022 Class A Common Stock 50K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As described in the registrant's registration statement on Form S-1 (File No. 333-259500) under the heading "Description of Securities - Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the registrant's initial business combination, or earlier at the option of the holder, on a one-for-one basis subject to certain adjustments and have no expiration date.
F2 Pursuant to certain redemption agreement between Bright Vision Sponsor LLC (the "Sponsor") and Ronald M. Razmi, a member of the Sponsor, shares of Class B common stock of the registrants were transferred by the Sponsor to Mr. Razmi in consideration for the redemption of such membership interest of the Sponsor entitling Mr. Razmi to receive such securities.